Catalizzatori

2-[[(Z)-Octadec-9-enoyl]amino]ethanesulfonic acid is a fatty acid that is metabolized by the liver. This compound has been shown to have insulin sensitizing and glucose regulating effects in mammalian cells. It also influences lipid metabolism, which may be due to its ability to regulate transcriptional activity of proteins such as amp-activated protein kinase and acetyl CoA carboxylase. 2-[(Z)-Octadec-9-enoyl]aminoethane sulfonic acid has been shown to improve metabolic profiles, including fatty acids and metabolites, in animals with heart disease and cancer. It may also be a useful biomarker for the diagnosis of metabolic disorders.

Buphenin hydrochloride is a non-steroidal anti-inflammatory drug (NSAID) that is used to treat symptoms of infectious diseases. It has been demonstrated to be an effective treatment for people with high blood pressure, and it also has a diuretic effect. Buphenin hydrochloride is structurally related to the NSAIDs ibuprofen and naproxen. It is believed that buphenin hydrochloride may have a number of clinical applications, including being used as an anti-inflammatory agent in treatment of rheumatoid arthritis and other auto-immune disorders. This drug has been shown to inhibit the growth of bacteria by binding to fatty acids in the bacterial cell membrane, which prevents them from forming hydrogen bonds with each other. The antimicrobial activity of buphenin hydrochloride may be due to its ability to disrupt the hydrogen bonding between fatty acids in the bacterial cell membrane.

Please enquire for more information about (PhMPhos)PdCl2, 1:1 complex with dichloromethane including the price, delivery time and more detailed product information at the technical inquiry form on this page

This kit contains the following products:
250mg of (08-46-0940-250mg) Methanesulfonato{N-[2-(di-1-adamantylphosphino)phenyl]morpholine}(2'-methylamino-1,1'-biphenyl-2-yl)palladium(II) dichloromethane adduct, min. 98% MorDalphos Palladacycle Gen. 4
250mg of (08-46-0330-250mg) Methanesulfonato(2-di-t-butylphosphino-2',4',6'-tri-i-propyl-1,1'-biphenyl)(2'-methylamino-1,1'-biphenyl-2-yl)palladium(II) dichloromethane adduct, min. 98% [t-BuXphos Palladacycle Gen. 4]
250mg of (08-46-0380-250mg) Methanesulfonato(2-dicyclohexylphosphino-2',6'-dimethoxy-1,1'-biphenyl)(2'-methylamino-1,1'-biphenyl-2-yl)palladium(II) dichloromethane adduct min. 98% [SPhos Palladacycle Gen. 4]
250mg of (08-46-0333-250mg) Methanesulfonato(2-dicyclohexylphosphino-3,6-dimethoxy-2',4',6'-tri-i-propyl-1,1'-biphenyl)(2'-methylamino-1,1'-biphenyl-2-yl)palladium(II), min. 98% [BrettPhos Palladacycle Gen. 4]
250mg of (08-46-0395-250mg) Methanesulfonato(2-dicyclohexylphosphino-2',6'-di-i-propoxy-1,1'-biphenyl)(2'-methylamino-1,1'-biphenyl-2-yl)palladium(II), min. 98% [RuPhos Palladacycle Gen. 4]
250mg of (08-46-0327-250mg) Methanesulfonato(2-dicyclohexylphosphino-2',4',6'-tri-i-propyl-1,1'-biphenyl)(2'-methylamino-1,1'-biphenyl-2-yl)palladium(II), min. 98% [XPhos Palladacycle Gen. 4]
250mg of (08-46-0388-250mg) Methanesulfonato[9,9-dimethyl-4,5-bis(diphenylphosphino)xanthene](2'-methylamino-1,1'-biphenyl-2-yl)palladium(II), 98% [Xantphos Palladacycle Gen. 4]
250mg of (08-46-0385-250mg) Methanesulfonato(tri-t-butylphosphino)(2'-methylamino-1,1'-biphenyl-2-yl)palladium(II), 98% [P(t-Bu)3 Palladacycle Gen. 4]
250mg of (08-46-0379-250mg) Methanesulfonato(tricyclohexylphosphino)(2'-methylamino-1,1'-biphenyl-2-yl)palladium(II), 98% [PCy3 Palladacycle Gen. 4]
,